Suppremol

Developer of therapeutics for the treatment of autoimmune diseases

placePlanegg, Bavaria, Germany calendar_todayFounded 2002 groups50 employees language suppremol.com

Innovation

22 patent families (13 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 830 times.

YearFilings
201412
20157
20168
20177
20186
20197
20207
20212
20222
20232
20241
20251

Investor mix

7 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital343%
Other / undisclosed457%
Coming soon